Report : Asia Pacific Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country
Infectious Diseases Segment to Register Highest CAGR in Asia Pacific Pharmaceutical Drug Delivery Market during 2020–2027
According to our new market research study on “Asia PacificPharmaceutical Drug DeliveryMarketForecast to 2027 –COVID-19 Impact and Global Analysis– by Route of Administration, Application, and End User,”the Asia Pacificpharmaceutical drug delivery market is projectedto reach US$ 4,73,700.1 million by2027 from US$ 2,77,589.9 million in2019. The market is estimated to grow at CAGR of 7.1% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacificpharmaceutical drug deliverymarketand the factors driving market growth along with those hindering it.
The Asia Pacificpharmaceutical drug deliverymarket, based on application, is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications.The cancer segment held the largest share of the market in 2019. However, the infectious diseases segment is estimated to register the highest CAGR during the forecast period owing to the growing adoption of unhealthy practices and lack of preventive care. Increasing number of vaccines and medications being introduced by pharmaceutical companies, on the back of their growing involvement in partnerships and increasing focus on developments, are likely to drive the demand for drug delivery devices during the forecast period.
The growth of the Asia Pacificpharmaceutical drug delivery marketis attributed to the increasing shortage of medicinesin the region. However, the availability of low R&D funding from governments in developing economiesrestrains the growth of the market.
Leading companies operating in the Asia Pacific pharmaceutical drug delivery marketare 3M,Antares Pharma, Bayer AG, BD, and GlaxoSmithKline plc, among others.
Asia PacificPharmaceutical Drug DeliveryMarket, By Country, 2019 (%)
The report segments Asia PacificPharmaceutical Drug Delivery Market as follows:
By Route of Administration
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Applications
By End User
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
By Country
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com